04/24/2024 3:31 PM | Amicus Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024 3:32 PM | Amicus Therapeutics (Filer)
| Form DEFA14A | |
04/16/2024 4:42 PM | Amicus Therapeutics (Issuer) Prout Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 3:27 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024 5:14 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 4:52 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 6:12 PM | Amicus Therapeutics (Issuer) Castelli Jeff (Reporting)
| Form 4/A | |
|
03/15/2024 6:13 PM | Amicus Therapeutics (Issuer) Clark David Michael (Reporting)
| Form 4/A | |
03/15/2024 6:14 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4/A | |
03/15/2024 6:15 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4/A | |
03/15/2024 6:10 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4/A | |
03/11/2024 4:36 PM | Amicus Therapeutics (Issuer) SBLENDORIO GLENN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:21 PM | Amicus Therapeutics (Issuer) MCGLYNN MARGARET G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:22 PM | Amicus Therapeutics (Issuer) RAAB MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 4:35 PM | Amicus Therapeutics (Subject) MCGLYNN MARGARET G (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 3:39 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 3:33 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 6:02 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 4:21 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:23 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:19 PM | Amicus Therapeutics (Subject) Clark David Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024 3:19 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 8:22 AM | Amicus Therapeutics (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/08/2024 3:40 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:22 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:22 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:44 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 3:45 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 4:20 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 3:18 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 4:09 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 3:25 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024 5:33 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 5:34 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 5:34 PM | Amicus Therapeutics (Issuer) Castelli Jeff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 5:35 PM | Amicus Therapeutics (Issuer) Clark David Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 5:35 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:06 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 5:07 PM | Amicus Therapeutics (Issuer) Prout Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 5:08 PM | Amicus Therapeutics (Issuer) Clark David Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:27 PM | Amicus Therapeutics (Subject) Clark David Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
What is Medicare Supplement Insurance? (Ad) Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here |
01/09/2024 3:27 PM | Amicus Therapeutics (Subject) Prout Samantha (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 8:09 AM | Amicus Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SC 13G | |
01/08/2024 6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 5:01 PM | Amicus Therapeutics (Issuer) Prout Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 5:01 PM | Amicus Therapeutics (Issuer) Clark David Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 5:02 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 5:03 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 5:03 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 5:04 PM | Amicus Therapeutics (Issuer) Castelli Jeff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:24 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:26 PM | Amicus Therapeutics (Issuer) Clark David Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:33 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:35 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:36 PM | Amicus Therapeutics (Issuer) Castelli Jeff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 5:17 PM | Amicus Therapeutics (Issuer) Harford Simon N.R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:30 PM | Amicus Therapeutics (Issuer) Prout Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:32 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:32 PM | Amicus Therapeutics (Subject) Rosenberg Ellen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023 4:18 PM | Amicus Therapeutics (Issuer) Amicus Therapeutics (Issuer) Castelli Jeff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:08 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:09 PM | Amicus Therapeutics (Issuer) Prout Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 3:21 PM | Amicus Therapeutics (Subject) Castelli Jeff (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023 3:25 PM | Amicus Therapeutics (Subject) Rosenberg Ellen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023 3:25 PM | Amicus Therapeutics (Subject) Prout Samantha (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 3:41 PM | Amicus Therapeutics (Issuer) Castelli Jeff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:20 PM | Amicus Therapeutics (Subject) Castelli Jeff (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023 4:54 PM | Amicus Therapeutics (Issuer) Clark David Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 4:55 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 4:56 PM | Amicus Therapeutics (Issuer) Rosenberg Ellen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 4:58 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:37 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023 3:31 PM | Amicus Therapeutics (Subject) MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
12/05/2023 4:03 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:07 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 5:03 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/17/2023 4:23 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 4:25 PM | Amicus Therapeutics (Filer)
| Form S-3ASR | |
11/08/2023 6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 6:37 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 6:38 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 6:57 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2023 3:23 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/05/2023 4:00 PM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 5:58 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 5:57 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 3:11 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 3:13 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 7:48 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/28/2023 11:00 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2023 6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Thousands of investors use this no cost solution | Do you? (Ad) In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve.
Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" |
09/18/2023 4:09 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:10 PM | Amicus Therapeutics (Subject) Quimi Daphne (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 3:13 PM | Amicus Therapeutics (Subject) Quimi Daphne (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 4:29 PM | Amicus Therapeutics (Issuer) Campbell Bradley L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 4:31 PM | Amicus Therapeutics (Issuer) Crowley John F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:11 PM | Amicus Therapeutics (Subject) Crowley John F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023 3:19 PM | Amicus Therapeutics (Subject) Campbell Bradley L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023 4:46 PM | Amicus Therapeutics (Issuer) Harford Simon N.R. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/23/2023 4:59 PM | Amicus Therapeutics (Issuer) Harford Simon N.R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |